» Articles » PMID: 31504418

2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk

Citing Articles

Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in Taiwan.

Tu K, Chang W, Lin H, Lin P, Wu Y, Lin C Eur J Med Res. 2025; 30(1):176.

PMID: 40089775 DOI: 10.1186/s40001-025-02431-8.


An innovative approach based on health surveillance for the prevention and early detection of cardiovascular diseases in a large cohort of healthcare workers.

Vimercati L, Sponselli S, Delvecchio G, Giannelli G, Caputi A, Sole S Sci Rep. 2025; 15(1):8942.

PMID: 40089576 DOI: 10.1038/s41598-025-93527-y.


Comparison of cardiac computed tomography recommendations in recent ESC vs. ACC/AHA guidelines.

Dayer N, Ciocca N, Antiochos P, Lu H, Auberson D, Meier D Int J Cardiovasc Imaging. 2025; .

PMID: 40085283 DOI: 10.1007/s10554-025-03375-0.


Effect of ABCG2 c.421 C> A (rs2231142) single nucleotide polymorphisms on the lipid-modulating efficacy of rosuvastatin: a meta-analysis.

Liu L, Deng Y, Li P, Zhang Z, Li H, Yang X BMC Cardiovasc Disord. 2025; 25(1):179.

PMID: 40082758 PMC: 11905716. DOI: 10.1186/s12872-025-04611-0.


Relationship between plasma atherogenic index and incidence of cardiovascular diseases in Chinese middle-aged and elderly people.

Zhao M, Xiao M, Zhang H, Tan Q, Ji J, Cheng Y Sci Rep. 2025; 15(1):8775.

PMID: 40082452 PMC: 11906849. DOI: 10.1038/s41598-025-86213-6.